PT2432804E - Anticorpos ou seus fragmentos direcionados contra um epítopo de staphylococcus aureus de isaa ou isab - Google Patents

Anticorpos ou seus fragmentos direcionados contra um epítopo de staphylococcus aureus de isaa ou isab Download PDF

Info

Publication number
PT2432804E
PT2432804E PT107204166T PT10720416T PT2432804E PT 2432804 E PT2432804 E PT 2432804E PT 107204166 T PT107204166 T PT 107204166T PT 10720416 T PT10720416 T PT 10720416T PT 2432804 E PT2432804 E PT 2432804E
Authority
PT
Portugal
Prior art keywords
antibodies
fragments
ala
ser
staphylococcus aureus
Prior art date
Application number
PT107204166T
Other languages
English (en)
Portuguese (pt)
Inventor
Knut Ohlsen
Udo Lorenz
Original Assignee
Julius Maximilians Universität Würzburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Julius Maximilians Universität Würzburg filed Critical Julius Maximilians Universität Würzburg
Publication of PT2432804E publication Critical patent/PT2432804E/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1271—Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
PT107204166T 2009-05-18 2010-05-18 Anticorpos ou seus fragmentos direcionados contra um epítopo de staphylococcus aureus de isaa ou isab PT2432804E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17913309P 2009-05-18 2009-05-18

Publications (1)

Publication Number Publication Date
PT2432804E true PT2432804E (pt) 2015-06-25

Family

ID=42316060

Family Applications (1)

Application Number Title Priority Date Filing Date
PT107204166T PT2432804E (pt) 2009-05-18 2010-05-18 Anticorpos ou seus fragmentos direcionados contra um epítopo de staphylococcus aureus de isaa ou isab

Country Status (13)

Country Link
US (3) US8609102B2 (https=)
EP (1) EP2432804B1 (https=)
JP (2) JP5882892B2 (https=)
CN (1) CN102695724B (https=)
AU (1) AU2010251156C1 (https=)
BR (1) BRPI1010911A2 (https=)
CA (1) CA2761886A1 (https=)
ES (1) ES2537437T3 (https=)
MX (1) MX2011012248A (https=)
PL (1) PL2432804T3 (https=)
PT (1) PT2432804E (https=)
RU (1) RU2560415C2 (https=)
WO (1) WO2010133600A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011012248A (es) * 2009-05-18 2012-02-29 Univ Wuerzburg J Maximilians Anticuerpos o sus fragmentos dirigidos contra un epitope de staphylococcus aureus de isaa o isab.
JP2014534169A (ja) * 2011-09-23 2014-12-18 ユリウス・マクシミリアンス−ウニヴェルジテート・ヴュルツブルクＪｕｌｉｕｓ Ｍａｘｉｍｉｌｉａｎｓ−Ｕｎｉｖｅｒｓｉｔａｅｔ Ｗｕｅｒｚｂｕｒｇ Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓエピトープ結合部位を形成するペプチドまたはペプチドの配置
EP3080160B1 (en) * 2013-12-13 2022-07-06 Rijksuniversiteit Groningen Antibodies against staphylococcus aureus and uses thereof
JP7525471B2 (ja) 2018-07-24 2024-07-30 メディミューン，エルエルシー Ｓ．アウレウス（Ｓ．ａｕｒｅｕｓ）クランピング因子Ａ（ＣｌｆＡ）に対する抗体
KR102341805B1 (ko) * 2019-11-27 2021-12-22 주식회사 하울바이오 황색포도상구균에 특이적으로 반응하는 항-IsaA G4 항체 및 이의 용도
KR102341804B1 (ko) * 2019-11-27 2021-12-22 주식회사 하울바이오 황색포도상구균을 억제하는 항-IsaA F10 항체 및 이의 용도
JP7750490B2 (ja) * 2019-12-17 2025-10-07 国立大学法人三重大学 線維症の評価および処置のための方法および組成物
WO2022250205A1 (ko) * 2021-05-25 2022-12-01 주식회사 하울바이오 항-IsaA F10 항체의 아토피 피부염 예방 및 개선 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4238806A1 (en) 1991-11-18 1993-05-27 Dainabot Co Methicillin-resistant staphylococcus aureus (MRSA)detection method - by detection of MRSA penicillin binding protein (PBP)2 antigen-antibody complex, and synthetic MRSA PBP2 peptides
FR2746398B1 (fr) * 1996-03-21 1998-04-30 Bio Merieux Anticorps specifique de staphylococcus aureaus, et utilisations
RU2144190C1 (ru) * 1998-01-13 2000-01-10 Катханов Али Муратович Способ диагностики стафилококковой инфекции
GB0014907D0 (en) * 2000-06-20 2000-08-09 Univ Sheffield Antigenic polypeptides
GB0127983D0 (en) * 2001-11-22 2002-01-16 Neutec Pharma Plc Treatment of micro-organism infection
WO2006076058A1 (en) * 2005-01-10 2006-07-20 Nabi Biopharmaceuticals Method of treating staphylococcus aureus infection
MX2011012248A (es) * 2009-05-18 2012-02-29 Univ Wuerzburg J Maximilians Anticuerpos o sus fragmentos dirigidos contra un epitope de staphylococcus aureus de isaa o isab.

Also Published As

Publication number Publication date
EP2432804A1 (en) 2012-03-28
CN102695724B (zh) 2016-08-24
EP2432804B1 (en) 2015-02-25
CN102695724A (zh) 2012-09-26
AU2010251156C1 (en) 2015-02-05
BRPI1010911A2 (pt) 2019-09-24
AU2010251156B2 (en) 2014-10-09
US20120100151A1 (en) 2012-04-26
US20160109449A1 (en) 2016-04-21
US9658230B2 (en) 2017-05-23
JP2016047828A (ja) 2016-04-07
CA2761886A1 (en) 2010-11-25
PL2432804T3 (pl) 2015-08-31
WO2010133600A1 (en) 2010-11-25
JP2012527423A (ja) 2012-11-08
RU2011146424A (ru) 2013-06-27
US8609102B2 (en) 2013-12-17
RU2560415C2 (ru) 2015-08-20
US20140072570A1 (en) 2014-03-13
ES2537437T3 (es) 2015-06-08
US9260511B2 (en) 2016-02-16
AU2010251156A1 (en) 2011-11-24
MX2011012248A (es) 2012-02-29
JP5882892B2 (ja) 2016-03-09

Similar Documents

Publication Publication Date Title
PT2432804E (pt) Anticorpos ou seus fragmentos direcionados contra um epítopo de staphylococcus aureus de isaa ou isab
AU2017203523B2 (en) Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)
CN103906535B (zh) 与葡萄球菌蛋白a的抗体相关的组合物和方法
ES2372686T3 (es) Anitcuerpos monoclonales dirigidos contra la proteína clfa y modo de empleo en el tratamiento y prevención de infecciones.
JP6494519B2 (ja) 抗ｌｐｓｏ１１抗体
TWI719938B (zh) 多重細菌感染之治療
CN104640878B (zh) 交叉反应的金黄色葡萄球菌抗体
CN114729033B (zh) 抗α-溶血素的抗体及其应用
KR20150094621A (ko) 스타필로코커스 아우레우스 표면 결정인자에 대한 항체
CA2341177A1 (en) Staphylococcal immunotherapeutics via donor selection and donor stimulation
BR112014011028B1 (pt) anticorpo biespecífico, composição, e, uso da composição
JP2008179634A (ja) グラム陽性細菌のリポタイコ酸に特異的なオプソニン性モノクローナルおよびキメラ抗体
CN109689090A (zh) 抗o2抗体及其用途
JP2015515492A (ja) 黄色ブドウ球菌（ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）疾患の間にコアグラーゼ活性を中和する抗体に関連した組成物および方法
JP2017505635A (ja) 黄色ブドウ球菌特異的抗体、それを用いた治療方法及び検出方法
CN101357942B (zh) 一种中和肠出血性大肠杆菌0157：H7志贺毒素Ⅱ的单克隆抗体、Fab抗体与应用
KR102241619B1 (ko) 병원체의 면역 억제 기능을 저해하는 모노클로날 항체, 그의 항원 결합 단편 및 이러한 항체를 생성하는 하이브리도마
EP0450573A2 (en) Antibodies for the treatment and diagnosis of Pseudomonas aeruginosa infections
CA2581330A1 (en) Methods and compositions relating to mannuronic acid specific binding peptides
CA2482747C (en) Vaccine composition for preventing meningococcal disease
BR112015006829B1 (pt) Anticorpo monoclonal ou porção de ligação ao antígeno do mesmo capaz de se ligar a gdf-15 humano, seu uso, composição farmacêutica, e kit
BR112016022013B1 (pt) Anticorpos monoclonais que se ligam a gdf-15 humano e kit compreendendo os mesmos